PulzCAD™
PulzCAD is a ground-breaking 2-lead wearable ECG device for cardiac stress testing that provides rapid AI driven analytics that aids Cardiologists in diagnosing CAD with much higher accuracy compared to traditional stress-testing technology.
18 million people die of heart attack each year globally
Worsening problem with changes in lifestyle, diet, and stress factors
No easy-to-use and sufficiently accurate ECG solutions to diagnose CAD early
Traditional ECG based stress testing uses outdated and grandfathered 50+ year old technology and concepts to identify changes in ECG patterns arising from stress-induced ischemia.
Unreliable, Inaccurate and inconsistent in detecting obstructive CAD
High number of false positives leads to unnecessary tests and patient anxiety
Bulky and cumbersome using 12-lead systems tethered to machine
PulzCAD™ enables exceptional diagnostic accuracy exhibiting ~ 90% sensitivity and ~75-80% specificity in early blinded clinical investigations, when compared to gold standard of percutaneous coronary angiogram results*.
Our innovative patent-pending cloud-based algorithms processes the high-resolution ECG data collected by the PulzCAD™ device during a stress test session. And within 5 mins of the session completion, the system presents advanced ECG feature charts that a cardiologists can assess and score to derive a more accurate CAD diagnosis.
Compact chest-wearable ECG device the size of a small matchbox collects high-resolution ECG data from just two leads to provide the unmatched accuracy in diagnosis.
Our AI-driven signal analytics and motion compensation algorithms extracts unique features even from the noisiest signals and offers unique ways to visualize individual ECG beats isolated at every heart-rate during the stress testing session.
Cardiologists can now review both the live ECG snapshots and the advanced PulzCAD reports containing ECG feature charts from anywhere right after a session.
PulzCAD™ is designed for use in hospitals and clinics and will soon be available in India where CDSCO approved medical devices can be commercially marketed.
form has been submitted!
sending data...
What exactly is PulzCAD™?
The PulzCAD™ device is a next-gen wearable Cardiac Stress Testing system consisting of a compact chest-wearable unit for acquiring 2-channels of high-resolution ECG data, coupled with a mobile/tablet to conduct the cardiac stress test while viewing the ECG and HR in real-time, and a cloud computing portal that runs the analytics on the data collected after the session is complete. Our system implements advanced algorithms for state-of-the-art noise and motion artifact reduction to extract medically explainable features and presents them as charts for Cardiologists to assess and get a final score that is indicative of presence or absence of CAD to varying degrees.
How Does PulzCAD™ provide superior results compared to the current technology?
PulzCAD™ uses a combination of patent-pending and proprietary algorithms that leverage advanced signal processing and AI analytics to cleanly extract ECG features from highly noisy ambulatory ECG signals during a stress test and generate human readable and interpretable features that Cardiologists can review and assess to generate a total score.
Does the PulzCAD™ device automatically generate a CAD diagnosis?
No. The Cardiologist is ultimately responsible for making the diagnosis based on the advanced insights provided by the system.
Is this product clinically validated?
We recently concluded a 3-year long clinical investigation at Medanta Medicity where the last 14 months of this study was spent in obtaining and analyzing double blinded dataset from patients who underwent a regular cardiac ECG stress test along with coronary angiogram or Cardiac CT, while we simultaneously and independently collected stress ECG data using the PulzCAD™ device from these patients. Insights derived from both the early stages as well as during the blind validation were leveraged to derive a unique scoring mechanism that cardiologists can apply to their diagnosis. We are in the process of publishing our study results.
Can I buy this product as a direct consumer?
PulzCAD™ is a class 2 medical device (pending CDSCO approval) that will be made available only to hospitals, clinics, and healthcare providers in India. If you are interested in being an early tester for a consumer version of this product that may become available in the future, please contact us.
How can my hospital/clinic get access to PulzCAD™?
Currently, this product will be made available only to a select group of Cardiologists who are up to date with research on this topic and feel comfortable working with this innovative technology. Please reach out to us if you are interested in being part of this early cohort of Cardiologist.
